Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9

Journal of Investigative Dermatology

Volumn 134, Issue 11, 2014, Pages 2693-2702

  Nikitorowicz Buniak, Joanna ^a   Shiwen, Xu ^a   Denton, Christopher P ^a   Abraham, David ^a   Stratton, Richard ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN B; CONNECTIVE TISSUE GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FILAGGRIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INVOLUCRIN; LACTATE DEHYDROGENASE; LORICRIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; TOLL LIKE RECEPTOR 4; VASCULOTROPIN; CTGF PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; DISEASE COURSE; EPIDERMIS; EPIDERMIS CELL; HUMAN; HUMAN CELL; KERATINOCYTE; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN SECRETION; SKIN FIBROBLAST; SKINFOLD THICKNESS; STRATUM CORNEUM; SYSTEMIC SCLEROSIS; CYTOLOGY; DERMIS; FIBROBLAST; FIBROSIS; INFLAMMATION; METABOLISM; PATHOLOGY; SKIN;

CALGRANULIN B; CELL DIFFERENTIATION; CELL PROLIFERATION; CONNECTIVE TISSUE GROWTH FACTOR; DERMIS; EPIDERMIS; FIBROBLASTS; FIBROSIS; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATION; KERATINOCYTES; SCLERODERMA, SYSTEMIC; SKIN; TOLL-LIKE RECEPTOR 4;

EID: 84908593116     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.253     Document Type: Article

References (61)

1. Abraham DJ, Eckes B, Rajkumar V., et al (2007) New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma. Curr Rheumatol Rep 9:136-43
2. Aden N, Nuttall A, Shiwen X., et al (2010) Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. J Invest Dermatol 130: 2191-200
3. Aden N, Shiwen X, Aden D., et al (2008) Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer. Rheumatology(Oxford) 47:1754-60
4. Andreasson K, Scheja A, Saxne T., et al (2011) Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis. J Intern Med 270:50-7
5. Beirne P, Pantelidis P, Charles P., et al (2009) Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. Eur Respir J 34:1376-82
6. Bellemare J, Roberge CJ, Bergeron D., et al (2005) Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars. J Pathol 206: 1-8
7. Benoit S, Toksoy A, Ahlmann M., et al (2006) Elevated serum levels of calciumbinding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br J Dermatol 155:62-6
8. Bhattacharyya S, Kelley K, Melichian DS., et al (2013) Toll-like receptor 4 signaling augments transforming growth factor-b responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol 182:192-205
9. Bogatkevich GS, Ludwicka-Bradley A, Highland KB., et al (2007) Downregulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways. Arthritis Rheum 56:3468-77
10. Cooper SM, Keyser AJ, Beaulieu AD., et al (1979) Increase in fibronectin in the deep dermis of involved skin in progressive systemic sclerosis. Arthritis Rheum 22:983-7
11. Davies CA, Herrick AL, Cordingley L., et al (2009) Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis. Rheumatology (Oxford) 48:876-82
12. Dazard JE, Gal H, Amariglio N., et al (2003) Genome-wide comparison of human keratinocyte and squamos cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer. Oncogene 22: 2993-3006
13. de Winter P, Leoni P, Abraham D (2008) Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors 26:80-91
14. Denton CP, Khan K, Hoyles RK., et al (2009) Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healing. J Invest Dermatol 129:194-204
15. El Ghalbzouri A, Ponec M (2004) Diffusible factors released by fibroblasts support epidermal morphogenesis and deposition of basement membrane components. Wound Repair Regen 12:359-67
16. Frazier K, Williams S, Kothapalli D., et al (1996) Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107:404-11
17. Frost J, Ramsay M, Mia R., et al (2012) Differential gene expression of MMP-1, TIMP-1 and HGF in clinically involved and uninvolved skin in South Africans with SSc. Rheumatology (Oxford) 51:1049-52
18. Funayama E, Chodon T, Oyama A., et al (2003) Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid. J Invest Dermatol 121:1326-31
19. Gailit J, Clark RA (1994) Wound repair in the context of extracellular matrix. Curr Opin Cell Biol 6:717-25
20. Ghaffari A, Kilani RT, Ghahary A (2009) Keratinocyte-conditioned media regulate collagen expression in Dermal fibroblasts. J Invest Dermatol 129:340-7
21. Ghahary A, Karimi-Busheri F, Marcoux Y., et al (2004) Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol 122:1188-97
22. Giusti L, Bazzichi L, Baldini C., et al (2007) Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J Rheumatol 34: 2063-9
23. Grotendorst GR, Rahmanie H, Duncan MR (2004) Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 18:469-79
24. Hamoen KE, Morgan JR (2002) Transient hyperproliferation of a transgenic human epidermis expressing hepatocyte growth factor. Cell Transplant 11:385-95
25. Jimenez SA, Bashey RI (1977) Collagen synthesis by scleroderma fibroblasts in culture. Arthritis Rheum 20:902-3
26. Jimenez SA, Feldman G, Bashey RI., et al (1986) Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts. Biochem J 237:837-43
27. Jinnin M, Ihn H, Mimura Y., et al (2005) Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts. J Invest Dermatol 124:324-30
28. Kahaleh MB, LeRoy EC (1999) Autoimmunity and vascular involvement in systemic sclerosis (SSc) Autoimmunity 31:195-214
29. Kawaguchi Y, Harigai M, Hara M., et al (2002) Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis. J Rheumatol 29:1877-83
30. Koskela A, Engstrom K, Hakelius M., et al (2010) Regulation of fibroblast gene expression by keratinocytes in organotypic skin culture provides possible mechanisms for the antifibrotic effect of reepithelialization. Wound Repair Regen 18:452-9
31. LeRoy EC, Black C, Fleischmajer R., et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202-5
32. Luger TA, Schwarz T (1990) Evidence for an epidermal cytokine network. J Invest Dermatol 95:100S-4SS
33. Maas-Szabowski N, Fusenig NE (1996) Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts. J Invest Dermatol 107:849-55
34. Maas-Szabowski N, Stark HJ, Fusenig NE (2000) Keratinocyte growth regulation in Defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol 114:1075-84
35. Maeda M, Matubara K, Hirano H., et al (1993) Pitting scars in progressive systemic sclerosis. Dermatology 187:104-8
36. Marionnet C, Bernerd F, Dumas A., et al (2003) Modulation of gene expression induced in human epidermis by environmental stress in vivo. J Invest Dermatol 121:1447-58
37. Meyer M, Muller AK, Yang J., et al (2011) The role of chronic inflammation in cutaneous fibrosis: fibroblast growth factor receptor deficiency in keratinocytes as an example. J Investig Dermatol Symp Proc 15:48-52
38. Milano A, Pendergrass SA, Sargent JL., et al (2008) Molecular subsets in the gene expression signatures of scleroderma skin. PLoSOne 3:e2696
39. Morley SM, Gaylarde PM, Sarkany I (1985) Epidermal thickness in systemic sclerosis and morphoea. Clin Exp Dermatol 10:51-7
40. Mukhopadhyay A, Tan EK, Khoo YT., et al (2005) Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast-populated collagen lattices. Br J Dermatol 152:639-45
41. Mustoe TA, Gurjala A (2011) The role of the epidermis and the mechanism of action of occlusive dressings in scarring. Wound Repair Regen 19(Suppl 1):s16-21
42. Nayeri F, Xu J, Abdiu A., et al (2006) Autocrine production of biologically active hepatocyte growth factor (HGF) by injured human skin. J Dermatol Sci 43:49-56
43. Niessen FB, Andriessen MP, Schalkwijk J., et al (2001) Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars. J Pathol 194:207-16
44. Nukui T, Ehama R, Sakaguchi M., et al (2008) S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. J Cell Biochem 104:453-64
45. Pablos JL, Santiago B, Galindo M., et al (1999) Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis. J Pathol 188: 63-8
46. Rossi A, Sozio F, Sestini P., et al (2010) Lymphatic and blood vessels in scleroderma skin, a morphometric analysis. Hum Pathol 41:366-74
47. Sato S, Nagaoka T, Hasegawa M., et al (2000) Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol 27:149-54
48. Shephard P, Hinz B, Smola-Hess S., et al (2004) Dissecting the roles of endothelin, TGF-beta and GM-CSF on myofibroblast differentiation by keratinocytes. Thromb Haemost 92:262-74
49. Sherriff-Tadano R, Ohta A, Morito F., et al (2006) Antifibrotic effects of hepatocyte growth factor on scleroderma fibroblasts and analysis of its mechanism. Mod Rheumatol 16:364-71
50. Shi-Wen X, Leask A, Abraham D (2008) Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 19:133-44
51. Shibata F, Miyama K, Shinoda F., et al (2004) Fibroblast growth-stimulating activity of S100A9 (MRP-14) Eur J Biochem 271:2137-43
52. Simon F, Bergeron D, Larochelle S., et al (2011) Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis. Burns 38:421-7
53. Smola H, Thiekotter G, Fusenig NE (1993) Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol 122:417-29
54. Szabowski A, Maas-Szabowski N, Andrecht S., et al (2000) c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103:745-55
55. Thorey IS, Roth J, Regenbogen J., et al (2001) The Ca2θ-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem 276:35818-25
56. Van Praet JT, Smith V, Haspeslagh M., et al (2011) Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study. Arthritis Res Ther 13:R35
57. Watt FM, Fujiwara H (2011) Cell-extracellular matrix interactions in normal and diseased skin. Cold Spring Harb Perspect Biol 3:a005124
58. Watt FM, Green H (1981) Involucrin synthesis is correlated with cell size in human epidermal cultures. J Cell Biol 90:738-42
59. Werner S, Krieg T, Smola H (2007) Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 127:998-1008
60. Xu X, Chen H, Zhu X., et al (2013a) S100A9 promotes human lung fibroblast cells activation through RAGE mediated ERK1/2 MAP-kinase and NF-kappaB dependent pathways. Clin Exp Immunol 173:523-35
61. Xu X, Wu WY, Tu WZ., et al (2013b) Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities. Clin Rheumatol 32:1501-10